The German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) is funding research into personalised treatment options for Noonan syndrome in the Stem Cell Unit at the University Medical Center Göttingen (UMG) with 467,580 euros.
The team led by MBExC member Dr Lukas Cyganek will conduct research for three years on the topic of “Identification of personalised treatment options for Noonan syndrome using genotype-phenotype correlation in patient-specific iPSCs”.
Dr. Lukas Cyganek, Department of Cardiology and Pneumology, Head of the Stem Cell Unit, University Medical Center Göttingen. Photo: umg/hzg
